Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 76Terminated 23Withdrawn 9Unknown 4Recruiting 4Active not recruiting 1

Sponsor Class

OTHER 279INDUSTRY 61NIH 33OTHER_GOV 18NETWORK 4FED 2UNKNOWN 1INDIV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 4Sarcoma 2

Conditions

Breast Neoplasms 13Leukemia, Myeloid, Acute 12Colorectal Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms 6Head and Neck Neoplasms 6Fallopian Tube Neoplasms 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leukemia 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Vulvar Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma 3Liver Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Fatigue 3Depression 3Central Nervous System Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Stress Disorders, Post-Traumatic 2Small Cell Lung Carcinoma 2

Interventions

brostallicin 1Taxes 1Psychiatric Rehabilitation 1Paclitaxel 1Methods 1Ifosfamide 1Educational Status 1Early Intervention, Educational 1Doxorubicin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × NETWORK × Ovarian Neoplasms × Clear all
NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

GOG Foundation

Phase 3 Unknown
637 enrolled 18 charts
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00958698 2019-03-12

Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

GOG Foundation

Phase NA Unknown
485 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01372787 2019-03-12

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

GOG Foundation

Unknown
103 enrolled
Gynecologic

Anxiety Disorders, Fallopian Tube Neoplasms, Fatigue, Nausea, Ovarian Neoplasms, Vomiting, Neurotoxicity Syndromes

NCT00410462 2014-08-08

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Unknown
118 enrolled
GynecologicSarcoma

Malignant mesenchymal tumor, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡